Search
for
Sort by
Research 751–780 of 775
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- 83 Transcriptomic meta-analysis and deconvolution approaches unveil cellular dynamics in scarring and non-scarring primary lymphocytic alopecias
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Recent advances in the genetics of alopecia areata
- Referee report. For: Molecular mediators involved in skin healing: a narrative review [version 1; peer review: 1 approved with reservations]
- 1,314
- Hair Loss in an 11-year-old
- Proceedings of the Ninth World Congress for Hair Research (2015)
- The Pathobiology of Skin Aging
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- European expert consensus statement on the systemic treatment of alopecia areata
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Medical Dermatology
- Three Types of Alopecia in One Patient: A Case of Central Centrifugal Cicatricial Alopecia, Alopecia Areata, and Telogen Effluvium
- Hair Disorders in Autoimmune Diseases
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- Under Development JAK Inhibitors for Dermatologic Diseases
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology